CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+9.19%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$709M
AUM Growth
-$77.6M
(-9.9%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-16.94%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
452
New
12
Increased
91
Reduced
283
Closed
40
Top Buys
| 1 |
Apple
AAPL
|
$9.08M |
| 2 |
Applied Materials
AMAT
|
$5.39M |
| 3 |
Arista Networks
ANET
|
$5.26M |
| 4 |
Amphenol
APH
|
$5.07M |
| 5 |
Alibaba
BABA
|
$4.29M |
Top Sells
| 1 |
Amgen
AMGN
|
$8.02M |
| 2 |
Adobe
ADBE
|
$7.95M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$7.6M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$6.84M |
| 5 |
Lam Research
LRCX
|
$5.23M |
Sector Composition
| 1 | Technology | 43.87% |
| 2 | Healthcare | 22.25% |
| 3 | Consumer Discretionary | 12.69% |
| 4 | Communication Services | 10.44% |
| 5 | Consumer Staples | 3.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Day One Biopharmaceuticals
DAWN
$759M
| $141K | 0.02% |
10,268
-6,549
| -39% | -$90.2K |
|
277
Veeva Systems
VEEV
$44.3B
| $141K | 0.02% |
771
| – | – |
|
278
Dollar Tree
DLTR
$20.4B
| $140K | 0.02% |
1,312
-1,409
| -52% | -$150K |
|
279
Xencor
XNCR
$597M
| $137K | 0.02% |
7,243
-4,512
| -38% | -$85.4K |
|
280
Disc Medicine
IRON
$2.09B
| $131K | 0.02% |
2,904
-1,737
| -37% | -$78.3K |
|
281
Prothena Corp
PRTA
$442M
| $130K | 0.02% |
6,318
-4,042
| -39% | -$83.4K |
|
282
Enliven Therapeutics
ELVN
$1.19B
| $129K | 0.02% |
5,526
-2,426
| -31% | -$56.7K |
|
283
4D Molecular Therapeutics
FDMT
$309M
| $127K | 0.02% |
6,073
-3,506
| -37% | -$73.6K |
|
284
Arcutis Biotherapeutics
ARQT
$1.94B
| $126K | 0.02% |
13,601
-5,013
| -27% | -$46.6K |
|
285
Ocular Therapeutix
OCUL
$2.21B
| $124K | 0.02% |
18,196
-3,003
| -14% | -$20.5K |
|
286
Schrodinger
SDGR
$1.4B
| $124K | 0.02% |
6,410
| – | – |
|
287
Genmab
GMAB
$16.8B
| $124K | 0.02% |
4,927
-3,097
| -39% | -$77.8K |
|
288
Collegium Pharmaceutical
COLL
$1.24B
| $124K | 0.02% |
3,844
-2,276
| -37% | -$73.3K |
|
289
Ironwood Pharmaceuticals
IRWD
$179M
| $122K | 0.02% |
18,676
-11,415
| -38% | -$74.4K |
|
290
Tarsus Pharmaceuticals
TARS
$2.42B
| $121K | 0.02% |
4,438
-2,129
| -32% | -$57.9K |
|
291
Innoviva
INVA
$1.32B
| $120K | 0.02% |
7,335
-4,837
| -40% | -$79.3K |
|
292
Cullinan Oncology
CGEM
$408M
| $118K | 0.02% |
6,771
-2,225
| -25% | -$38.8K |
|
293
Arm
ARM
$144B
| $116K | 0.02% |
+711
| New | +$116K |
|
294
Maravai LifeSciences
MRVI
$341M
| $112K | 0.02% |
15,604
-9,830
| -39% | -$70.4K |
|
295
MongoDB
MDB
$26.2B
| $110K | 0.02% |
441
+115
| +35% | +$28.7K |
|
296
TJX Companies
TJX
$157B
| $110K | 0.02% |
1,000
| – | – |
|
297
Warner Bros
WBD
$29.1B
| $110K | 0.02% |
14,732
+3,728
| +34% | +$27.7K |
|
298
Tango Therapeutics
TNGX
$760M
| $108K | 0.02% |
12,552
-7,017
| -36% | -$60.2K |
|
299
Zai Lab
ZLAB
$3.34B
| $105K | 0.01% |
6,045
-3,485
| -37% | -$60.4K |
|
300
AbCellera Biologics
ABCL
$1.24B
| $102K | 0.01% |
34,546
-21,760
| -39% | -$64.4K |
|